A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Clinical trial NCT06937203 · RECRUITING
Trial details
- NCT number
- NCT06937203
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2027-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.